Immunohistochemical detection of the BRAF V600E mutation in melanoma patients with monoclonal antibody VE1
Authors:
- 31 October 2014
- journal article
- research article
- Published by Wiley in Pathology International
- Vol. 64 (12) , 601-606
Abstract
A novel mutation‐specific monoclonal antibody VE1 was generated to detect BRAF V600E mutation with immunohistochemistry. This study aims to investigate the sensitivity and specificity of immunohistochemistry compared with conventional Sanger sequencing and to evaluate whether IHC would become the routine screening method of BRAF V600E mutation. A total of 84 cases of melanoma lesion specimens were selected to make the tissue microarray and to perform IHC with VE1 antibody. Simultaneously Sanger sequencing was applied to test and verify. VE1 has a high specificity (100%) and sensitivity (72.2%), and the concordance between the two techniques is excellent (93.8% cases coherent and kappa = 0.801). As a rapid, cost‐effective method, IHC may become the routine diagnostic means for the detection of BRAF V600E mutation of malignant melanomas in the near future, and the recommended detection process is initial immunohistochemical staining for positive cases, followed by molecular techniques for negative or ambiguous cases.Keywords
This publication has 27 references indexed in Scilit:
- Immunohistochemistry Is Highly Sensitive and Specific for the Detection of V600E BRAF Mutation in MelanomaAmerican Journal of Surgical Pathology, 2013
- Diagnostic value of immunohistochemistry for the detection of the BRAF mutation in primary lung adenocarcinoma Caucasian patientsAnnals of Oncology, 2012
- Immunohistochemical Detection of the BRAF V600E-mutated Protein in Papillary Thyroid CarcinomaAmerican Journal of Surgical Pathology, 2012
- Survival in BRAF V600–Mutant Advanced Melanoma Treated with VemurafenibNew England Journal of Medicine, 2012
- Immunohistochemical testing of BRAF V600E status in 1,120 tumor tissue samples of patients with brain metastasesActa Neuropathologica, 2011
- Improved Survival with Vemurafenib in Melanoma with BRAF V600E MutationNew England Journal of Medicine, 2011
- Application of a BRAF Pyrosequencing Assay for Mutation Detection and Copy Number Analysis in Malignant MelanomaThe Journal of Molecular Diagnostics, 2007
- MelanomaNew England Journal of Medicine, 2006
- Detection of the BRAF V600E mutation in melanocytic lesions using the ligase detection reactionJournal of Cutaneous Pathology, 2005
- Mutations of the BRAF gene in human cancerNature, 2002